Milk Peptides (Lactium)
Lactium is a tryptic hydrolysate of bovine alpha-s1 casein containing alpha-casozepine, a peptide that binds GABA-A benzodiazepine sites without benzodiazepine dependence. Several small randomized trials show modest reductions in stress symptoms and sleep disturbance — real but small effects, from a research base that is largely manufacturer-linked.
What the science says
- Reduces stress-related symptoms in small randomized trials Moderate evidence
A double-blind placebo-controlled trial in women with stress-related symptoms gave 150 mg/day alpha-s1 casein hydrolysate for 30 days and found significant improvement in digestive, cardiovascular, emotional and social domains of a stress symptom scale versus placebo. An earlier crossover study in healthy men showed 400 mg blunted systolic blood pressure and cortisol responses to a standardized mental and physical stress challenge.
- Improves subjective sleep quality in people with disturbed sleep Moderate evidence
A double-blind randomized placebo-controlled crossover study of alpha-s1 casein hydrolysate in adults with sleep disturbance reported improvements in sleep quality measures over placebo. Effects were modest and largely subjective (questionnaire-based) rather than polysomnographic, and sample sizes across the Lactium literature are in the tens, not hundreds.
- Binds benzodiazepine sites without benzodiazepine liabilities Moderate evidence
Mechanistic work shows alpha-casozepine's anxiolytic-like effect in animals depends on GABA-A receptor benzodiazepine binding sites — the effect is abolished by flumazenil-sensitive manipulations — yet unlike benzodiazepines it does not produce sedation, tolerance, amnesia or dependence in animal models. This makes it pharmacologically interesting, though animal receptor mechanism does not by itself predict clinical magnitude in humans.
- The research base is small and heavily industry-linked Limited evidence
Most human Lactium trials involve the ingredient manufacturer, use fewer than 60 participants, run 2-4 weeks, and rely on self-report scales. No large independent replication or meta-analysis exists. The honest read: plausible mechanism, consistent small positive results, weak independence — treat it as promising rather than established.
Dosage & safety
How to take it
Interactions
With other supplements
- melatonin, valerian and other evening sedative supplements
Sedative effects can add up and leave you groggy the next morning. introduce one at a time and avoid driving soon after an evening dose
Well-established interactions only — this is not a complete list. Always tell your doctor and pharmacist what you take.
Frequently asked questions
Does Lactium reduce stress?
Lactium (milk peptides) has moderate evidence for modest stress relief: in a trial of women with stress symptoms, 150 mg/day for 30 days improved several domains of a stress scale versus placebo. The trials are small and largely manufacturer-linked.
Does Lactium help you sleep?
A small crossover trial of Lactium in adults with disturbed sleep reported better subjective sleep quality than placebo — moderate evidence. Effects were modest and questionnaire-based rather than measured in a sleep lab.
How should I take Lactium?
Take 150-300 mg of Lactium, in the evening about an hour before bed or 1-2 hours before a stressor you can anticipate. Allow 2-4 weeks of daily use before judging it.
Is Lactium safe if I am lactose intolerant?
Generally yes: Lactium is a milk protein hydrolysate, not lactose, though it is unsuitable if you have cow's milk protein allergy. It may add to the sedative effect of benzodiazepines, alcohol or other sedatives.
Scientific references
Where to buy
Protocol for Life Balance, Clinical Stress Relief , 60 Veg Capsules
Ships to 180+ countries · welcome discount for new customers
Referral link — this site may earn a commission on purchases.
Related in Sleep & relaxation
- Melatonin Moderate evidence
- Magnesium Moderate evidence
- L-Theanine Moderate evidence
- L-Tryptophan Moderate evidence
- Glycine Limited evidence
- GABA Limited evidence